| ASSET | YEAR | % RETURN |
|---|---|---|
Cato (CATO) | 1991 | 1,916.65% |
Envela (ELA) | 1991 | 990.91% |
BioLife Solutions (BLFS) | 1991 | 785.11% |
Biomerica (BMRA) | 1991 | 652.94% |
Magna International (MGA) | 1991 | 610.56% |
Jack Henry & Associates (JKHY) | 1991 | 535.16% |
Oppenheimer (OPY) | 1991 | 478.93% |
Brightstar Lottery (BRSL) | 1991 | 441.14% |
Abeona Therapeutics (ABEO) | 1991 | 433.51% |
Gencor Industries (GENC) | 1991 | 411.21% |
CEL-SCI (CVM) | 1991 | 410% |
Vicor (VICR) | 1991 | 398.56% |
Heron Therapeuti (HRTX) | 1991 | 394.12% |
Mesa Laboratories (MLAB) | 1991 | 383.33% |
Veru (VERU) | 1991 | 325.4% |
Toll Brothers (TOL) | 1991 | 309.11% |
Bio-Techne (TECH) | 1991 | 308.09% |
STAAR Surgical (STAA) | 1991 | 306.95% |
Charles Schwab (SCHW) | 1991 | 299.71% |
Educational Development (EDUC) | 1991 | 299.7% |
Plexus (PLXS) | 1991 | 289.75% |
Merit Medical Systems (MMSI) | 1991 | 274.31% |
Bel Fuse A (BELFA) | 1991 | 268.44% |
Celldex Therapeutics (CLDX) | 1991 | 266.67% |
Amgen (AMGN) | 1991 | 266.54% |